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78 Abstract. Titanate nanotubes can be used as drug delivery systems, but limited information is available on
9 their interactions with intestinal cells. In this study, we investigated the cytotoxicity and cellular uptake of
10 titanate nanotubes on Caco-2 monolayers and found that up to 5 mg/ml concentration, these nanotubes
11 are not cytotoxic and not able to permeate through the intestinal cell layer. Transmission electron
12 microscopic experiments showed that titanate nanotubes are not taken up by cells, only caused a high-
13 density granulation on the surface of the endoplasmic reticulum. According to these results, titanate
14 nanotubes are suitable systems for intestinal drug delivery.
15
16 KEY WORDS: Caco-2 cells; cytotoxicity; titanate nanotubes.
17
18 INTRODUCTION
19 Carbon and titanate nanotubes (TiNT) are specific types
20 of nanoparticles (1,2) with the advantage that small particles
21 of active pharmaceutical ingredients (APIs) can be incorpo-
22 rated into the nanotube cavity (3). With nanotube technology,
23 it is possible to prepare stable drug delivery systems, but their
24 safety is a key issue that remains to be resolved. Several
25 publications have reported on the application of carbon nano-
26 tubes (4,5), but toxicity studies have not been conclusive (6).
27 Accordingly, the absorption, toxicity and cellular effects of
28 nanotubes should be investigated for a full characterization
29 of their effects. Only limited information is available
30 concerning the cellular effects of TiNT in the gastrointestinal
31 tract, and we have therefore studied their toxicity and absorp-
32 tion through the use of the Caco-2-cell line.
33
34 MATERIALS AND METHODS
35 Preparation of Titanate Nanotubes
36 TiNTs were synthesized by a simple alkali hydrothermal
37 method involving the alkaline recrystallization of anatase TiO2,
38 as described previously (7,8). The material obtained was
39characterized by transmission electron microscopy (TEM;
40Philips CM10, 100 kV), scanning electron microscopy (SEM;
41Hitachi S4700; Hitachi Scientific Instruments Ltd., Japan) and
42X-ray diffractometry (XRD; Rigaku miniflex 2000, CuKα). Its
43specific surface area was determined from nitrogen adsorption
44measurements performed at 77 K in a Quantachrome Nova
453000e instrument and analysed by the BET method.
46Cell Culture and MTT Cell Viability Test
47Caco-2 cells were used for permeability and cytotoxicity
48experiments. Cells were seeded onTranswell® (Corning Costar,
49USA) filters as reported previously (9). The cellular uptake of
50TiNTwas examined by TEM as described in Fig. 3. To test TiNT
51cytotoxicity by the MTT method (10), Caco-2 cells were seeded
52in 96-well plates, and cells were exposed to increasing TiNT
53concentrations in Hank’s balanced salt solution (HBSS) at
5437°C for 120 min. Dye absorbance was measured at 570 nmwith
55a FLUOstar OPTIMA microplate reader (BMG LABTECH,
56Offenburg, Germany), and the values were corrected for the
57background absorbance, measured at 690 nm. Cell viability was
58expressed as a percentage of the untreated control. All reagents
59were purchased from Sigma-Aldrich (Budapest, Hungary).
60Caco-2 Permeability Experiments
61In permeability experiments, Caco-2 monolayers were
62incubated apically with TiNT at 2 mg/ml for 120 min. Then,
63the permeated amount of Ti was measured with an energy
64dispersive X-ray fluorescence analyser (Philips MiniPal PW
654025, Philips Analytical, the Netherlands).
66Morphology Studies
67TEM. The morphology of the synthesized titanate nano-
68tubes was characterized with the aid of a TECNAI G2 20 X-
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F69 Twin high-resolution transmission electron microscope
70 operating at an accelerating voltage of 200 kV. Samples for
71 TEM measurements were drop casted onto carbon-coated
72 copper grids from an acetone suspension.
73
74 SEM. The surface of the nanotubes was tested with a
75 scanning electron microscope (Hitachi S4700; Hitachi Scien-
76 tific Instruments Ltd., Japan). A SEM sputter coating unit
77 (Polaron E5100; VG Microtech, UK) was used to charge the
78 surfaces for the SEM measurements.
79
80
81 RESULTS
82 The formation of the TiNT was examined by TEM and
83 SEM. Figure 1 shows that the length of the nanotubes was 50–
84 150 nm and their diameter was 6–10 nm. The tubular structure
85 can also be identified. A typical TiNT has four walls and an
86 interlayer of spacing approximately 0.7 nm. The specific surface
87 area of the TiNT is ∼185 m2g−1 due to the specific morphology.
88 The as-synthesized sample (Na-form) exhibited broad peaks of
89 low intensity, which are quite difficult to index, but the profile
90could be referred to as reflections (around 10°, 25°, 28° and 49°)
91of sodium trititanate, Na2Ti3O7 (JCPDS no. 31-1329).
92Cytotoxic effects could not be detected with the MTT
93method up to a nanotube concentration of 5 mg/ml (Fig. 2).
94This is in accordance with the findings that titanium dioxide
95(TiO2) nanoparticles at 1 mg/ml did not cause the death of
96Caco-2 cells (11) and that titania nanotubes up to 1.1 mg/ml
97are non-cytotoxic on A549 lung epithelial cells (12).
98In permeability experiments, no detectable amount of Ti
99was found in the basolateral side of the monolayers, indicating
100that intestinal cells are impermeable for TiNT. Monolayers
101were also treated with 0.5 mg/ml TiNT, fixed with 4% glutar-
102aldehyde and processed for TEM investigations. Nanotubes
103could not be identified in the Caco-2 cells demonstrating
104(Fig. 3) that these nanotubes were not taken up by the cells.
105Nevertheless, high-density granules which had no nanotubular
106morphology (Fig. 3c, arrows) could be observed on the surface
107of the endoplasmic reticulum in the treated cells. These gran-
108ules may be titanium dioxide particles formed from the nano-
109tubes during the incubation or TiO2 Q3impurities. This is in
110accordance with a previous report that at ≥10 μg/ml, TiO2
111nanoparticles are able to enter Caco-2 cells and cross a Caco-2
112monolayer by transcytosis (11).
Fig. 1. TEM (a) and SEM (b) images of TiNT
Fig. 2. Cytotoxicity of TiNT and TiO2. Caco-2 cells were treated with nanotubes and titanium
dioxide in different concentrations for 120 min, and their viability was determined by MTT tests.
Untreated control was considered as 100%, and data are expressed as the percentage of untreated
control. Positive control, 2% Triton X-100 solution. There were no significant differences among
TiNT- and TiO2-treated samples (p>0.05), while Triton X-100 exerted complete cell death (p<0.05).
Data are means of three independent experiments±SD
Fenyvesi et al.
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113DISCUSSION
114TiO2 is a safe, widely used excipient in pharmaceutical
115technology, whereas TiNT is not yet applied. Our study has
116furnished evidence that TiNT does not cause cellular toxicity
117in short-term treatment and does not penetrate Caco-2 cells,
118but does lead to a high-density granulation on the surface of
119the endoplasmic reticulum. In vitro cytotoxicity assays (i.e.
120MTT, LDH) can predict irritancy and delayed toxicity of
121harmful agents (13). Nevertheless, cytotoxicity data alone
122are not necessarily predictive of in vivo issues (14), but
123complemented with results of morphology studies, the
124in vivo toxicity data may be estimated (15). Even if titanate
125nanotubes are unpermeable on intestinal cell layer, they de-
126liver drug particles to intestinal cell surface and can also
127increase the solubility of active substances. The aqueous solu-
128tions are stable for months. That may be the reason that TiNTs
129provide new possibilities for the formulation of oral drug
130delivery systems (16).
131CONCLUSION
132It may be concluded that TiNT is a safe system for intes-
133tinal formulations, as they are practically not absorbed from
134the intestine.
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